Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Short-Term Debt repayments (2022 - 2024)

Fortress Biotech (FBIO) has 5 years of Short-Term Debt repayments data on record, last reported at $5.0 million in Q4 2024.

  • For Q4 2024, Short-Term Debt repayments fell 65.8% year-over-year to $5.0 million; the TTM value through Sep 2025 reached $19.6 million, up 34.33%, while the annual FY2024 figure was $10.0 million, 31.52% down from the prior year.
  • Short-Term Debt repayments reached $5.0 million in Q4 2024 per FBIO's latest filing, up from -$50000.0 in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $14.6 million in Q4 2023 and bottomed at -$50000.0 in Q3 2024.
  • Average Short-Term Debt repayments over 3 years is $4.9 million, with a median of $5.0 million recorded in 2022.
  • The widest YoY moves for Short-Term Debt repayments: up 65.8% in 2024, down 4900.0% in 2024.
  • A 3-year view of Short-Term Debt repayments shows it stood at $5.0 million in 2022, then surged by 192.4% to $14.6 million in 2023, then crashed by 65.8% to $5.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt repayments were $5.0 million in Q4 2024, -$50000.0 in Q3 2024, and $14.6 million in Q4 2023.